University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 10 of 20
What is the Prevalence of Female Pelvic Floor Disorders in Minnesota?
NCT03536221
Evaluation of Diaphragm Movement After an Interscalene Block
NCT03636542
Liposomal Bupivacaine Interscalene Blocks for Rotator Cuff Repair
NCT03587584
Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes
NCT03479515
Pec Infiltration With Liposomal Bupivacaine for Breast Surgery
NCT03599635
Home-Based High Intensity Interval Training Intervention for Low Active Adults
NCT03479177
Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3
NCT03079037
Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System
NCT04406740
Metabolism, Breastmilk, and Microbiome
NCT03522597
Feasibility Testing of a New Way to Support the Jaw During 3rd Molar Extractions
NCT03512769
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
NCT03272685
Recurrent Hypoglycemia in Type 1 Diabetes (Aim 1)
NCT03410277
Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients
NCT03437577
Cystic Fibrosis and Cognitive Function
NCT03820349
Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops
NCT03132961
Whole Grain and Fiber Addition Study
NCT03623308
Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course
NCT04382716
Grocery Assistance Program Study for Families
NCT03363048
Implementation of Mind-Body Practices in an Online Community of Caring (CaringBridge)
NCT05002842
High-Intensity Aerobic Lifelong Training--AF
NCT03241433
Single-session tDCS in Cerebral Palsy
NCT03635775
Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format
NCT03300232
Metabolism of Deuterated NNN in Smokeless Tobacco Users
NCT02414477
Neural Correlates of Cognition and Mood
NCT04573569
Mindful Movement for Physical Activity and Wellbeing in Older Adults
NCT03114709
Lung Volume Recruitment Combined With Expiratory Muscle Strength Training in ALS
NCT03202017
Neural Correlates of Reward and Symptom Expression in Anorexia Nervosa
NCT03275545
Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
NCT03402243
An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression
NCT03222570
Osmotic Agent Use in Middle Cerebral Artery Stroke
NCT04156490
Oral Cell DNA Adducts in Smokers
NCT03285893
Weight Loss With Meal-Replacement Therapy in Teens
NCT03137433
Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin
NCT03259581
Effect of a Non-Invasive Brain Stimulation Technique on Smoking Cessation Behaviors
NCT03386253
MRI Findings of Epiphyseal Growth Plate in Healthy Children
NCT03190200
Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease
NCT02636283
Development of Upper Limb Motor Scale to Measure Quality of Movement and Body Awareness in Stroke
NCT03328468
Faith Based Pilot Intervention to Reduce Tobacco Use Among Somali Males
NCT03379142
Vitamin C and Septic Shock
NCT03338569
Safety and Feasibility of Imaging at 10.5 Tesla
NCT03346707
ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
NCT03119571
Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation
NCT03114488
Cognitive Training and tDCS for Children With FASD
NCT03361293
Community-based Intervention Effects on Older Adults' Physical Activity
NCT03326141
Leg Exercise During ECMO
NCT03135210
Virtual Reality for Anxiety Management in Mechanically Vented Patients
NCT03169374
Effects of Change in Insulin Resistance and Systemic Inflammation on Brain Structure and Function
NCT03215888
Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cardiac Surgery
NCT04127825
Assessment of Markers of Stress in Acute Ischemic Stroke With Hyperglycemia
NCT03318679
Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
NCT03026790
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.